Debt to EBITDA ratio Analysis of Novavax Inc - Deep Dive


Debt to EBITDA of NVAX
Dec-23
-0.306
Very Poor Debt to EBITDA
Dec-22
-0.858
Very Poor Debt to EBITDA
Growth
64.35
%
Debt to EBITDA Analysis of Novavax Inc
Debt to EBITDA Ratio of NVAX rose handsomely by 64.35 % this year.
Debt to EBITDA Ratio with value of -0.270 was highest in Year Dec-21 in last Five Years.
Debt to EBITDA Ratio with value of -2.80 was lowest in Year Dec-19 in last Five Years.
Latest Debt to EBITDA Ratio with value of -0.306 is Greater than Average Debt to EBITDA of -1.17 in last five years.
Other Debt to EBITDA Related Info of NVAX that may interest you.
Novavax Inc Overview
CodePricePrevious PricePrice ChangeSector
NVAX15.0315.25 1.44 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization.    more ..
Debt to EBITDA Formula

Debt to EBITDA Related Ratios
CashFlowFromOperationToDebtDebtToCapitalEVToEBITDA

Tsr Stability Index
Poor Stability Stock
FY - Historical Debt to EBITDA of Novavax Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Debt to EBITDA-0.306-0.858-0.270-1.62-2.80-2.09-3.98
Change64.35 %-217.46 %83.30 %42.30 %-34.03 %47.39 %-197.04 %
You are view first 7 Records. Log in to view all 28 in Premium view
FY Chart of Debt to EBITDA of Novavax Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)